Company Filing History:
Years Active: 1998-2003
Title: Michel Goedert - Innovator in Alzheimer's Research
Introduction
Michel Goedert is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of neuroscience, particularly in the study of Alzheimer's disease. With a total of three patents to his name, Goedert's work focuses on understanding the mechanisms underlying neurodegenerative disorders.
Latest Patents
One of his latest patents involves MAP kinases, specifically polypeptides, polynucleotides, and their uses. This invention relates to a method for identifying compounds that block the activation of stress-activated protein kinases, such as SAPK4 and SAPK3, by SKK3. The method includes assessing the interaction between the kinase and the compound to determine its effectiveness.
Another significant patent addresses the screening of agents for potential use in treating Alzheimer's disease. This method involves reacting tau protein with a suitable sulphated carbohydrate to form filaments and monitoring the presence of these filaments. The invention aims to identify agents that may inhibit the assembly of paired helical filaments, which could have therapeutic implications for delaying the effects of Alzheimer's disease.
Career Highlights
Throughout his career, Michel Goedert has worked with esteemed institutions, including the Medical Research Council and Duke University. His research has been pivotal in advancing our understanding of Alzheimer's disease and related conditions.
Collaborations
Goedert has collaborated with notable colleagues, including Warren
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.